4//SEC Filing
Herde Kevin 4
Accession 0000899243-22-003418
CIK 0001823239other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:00 PM ET
Size
11.2 KB
Accession
0000899243-22-003418
Insider Transaction Report
Form 4
Herde Kevin
Chief Financial Officer
Transactions
- Award
Class A Common Stock
2021-04-30$22.95/sh+497$11,406→ 497 total - Award
Employee Stock Option (Right to Buy)
2022-01-25+36,200→ 36,200 totalExercise: $26.32Exp: 2032-01-25→ Class A Common Stock (36,200 underlying) - Award
Class A Common Stock
2021-10-31$22.95/sh+392$8,996→ 889 total - Award
Class A Common Stock
2022-01-25+19,500→ 20,389 total
Footnotes (3)
- [F1]The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 889 shares of Class A Common Stock was also exempt pursuant to Rule 16b-3(c).
- [F2]Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of February 15, 2023, February 15, 2024, and February 15, 2025, subject to the reporting person's continued employment with the Issuer.
- [F3]Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 1/48th on March 15, 2022 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer.
Documents
Issuer
MARAVAI LIFESCIENCES HOLDINGS, INC.
CIK 0001823239
Entity typeother
Related Parties
1- filerCIK 0001671595
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 4:00 PM ET
- Size
- 11.2 KB